Market Estimates
Valuation Metrics
Financials
Trading Trends
GILD News & Events
Events Timeline

No data
News
People Also Watch
Frequently Asked Questions
What is Gilead Sciences Inc (GILD) stock price today?
The current price of GILD is 124.35 USD — it has increased 2.46 % in the last trading day.
What is Gilead Sciences Inc (GILD)'s business?
Gilead Sciences, Inc. is a biopharmaceutical company. It is engaged in advancing medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis, COVID-19, cancer, and inflammation. It is focused on discovering, developing, and delivering medicines to address unmet medical needs in virology, oncology, and other therapeutic areas. Its portfolio of marketed products includes Biktarvy, Genvoya, Descovy, Complera/Eviplera, Symtuza, Truvada, Stribild, Sunlenca, Epclusa, Vemlidy, Harvoni, Viread, Livdelzi, Veklury, Yescarta, Tecartus, Trodelvy, AmBisome, and Letairis. Its product candidates include Bulevirtide, Lenacapavir, Axicabtagene ciloleucel, Sacituzumab govitecan-hziy, and others. It also develops the HB-400 program and the HB-500 program. It develops therapies that are intended to provide functional cures for hepatitis B virus and human immunodeficiency virus-1. It has a cancer program, namely TREX1. It operates in more than 35 countries worldwide.
What is the price predicton of GILD Stock?
Wall Street analysts forecast GILD stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for GILD is 135.00 USD with a low forecast of 105.00 USD and a high forecast of 150.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
What is Gilead Sciences Inc (GILD)'s revenue for the last quarter?
Gilead Sciences Inc revenue for the last quarter amounts to 7.77B USD, increased 2.97 % YoY.
What is Gilead Sciences Inc (GILD)'s earnings per share (EPS) for the last quarter?
Gilead Sciences Inc. EPS for the last quarter amounts to 2.43 USD, increased 143.00 % YoY.
What changes have occurred in the market's expectations for Gilead Sciences Inc (GILD)'s fundamentals?
How many employees does Gilead Sciences Inc (GILD). have?
Gilead Sciences Inc (GILD) has 17600 emplpoyees as of January 08 2026.
What is Gilead Sciences Inc (GILD) market cap?
Today GILD has the market capitalization of 150.57B USD.


![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F98ead2b13cd3cb065cd8250ed6fc08625cdc0c42d3c90bf373c199aeb6cec291.png&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F20260108010328_4673fd7ef5bedbff96f3b346832d82c0.jpeg&w=384&q=75)
![an image of [object Object]](/_next/image?url=https%3A%2F%2Fd5bp8bijhhba2.cloudfront.net%2Fimage%2Fcover_image%2F023251b6b486daed7424fe2962433572dde9b4a4fff39ecfcbce04485d9407e9.jpg&w=384&q=75)